论文部分内容阅读
The international Prognostic Index for patients with CLL (CLL-IPI): An international meta-analysis
【作 者】
：
【机 构】
：
International CLL-IPI working group Department I
【出 处】
：
2015年临床肿瘤学新进展学术研讨会
【发表日期】
：
2015年3期
其他文献
Phase Ⅱ/Ⅱ study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung c
会议
Final overall survival (OS) results of the phase Ⅲ PROCLAIM trial: Pemetrexed (Pem), cisplatin (Cis)
会议
Randomized phase Ⅲ trial of customized adjuvant chemotherapy (CT) according BRCA-1 expression levels
会议
Randomized phase Ⅱ, three-arm trial of lenvatinib (LEN), everolimus (EVE), and LEN+EVE in patients (
会议
Final clinical results of a randomized phase Ⅱ international trial of everolimus vs. sunitinib in pa
会议
A randomized phase Ⅱ study of paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimu
会议
Docetaxel and/or zoledronic acid for hormone-na(i)ve prostate cancer: First overall survival results
会议
Results of ARIEL2: a Phase 2 trial to prospectively identify ovarian cancer patients likely to respo
会议